FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to ...
Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh® ...